These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3002262)

  • 1. Antiherpes activity of 5-(2-bromoethyl)-2'-deoxyuridine.
    La Colla P; Gelli G; Mura L; Landini MP; Corrias MV; Pani A; Marongiu ME
    Antiviral Res; 1985; Suppl 1():29-34. PubMed ID: 3002262
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions between virus and antiviral compounds in the host cell.
    Harmenberg J
    Med Biol; 1984; 62(6):299-303. PubMed ID: 6099858
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of acyclovir and presence of cellular and viral thymidine kinase activity in herpes simplex virus infected cells. Brief report.
    Harmenberg J; Källander CF; Gronowitz JS
    Arch Virol; 1982; 74(2-3):219-25. PubMed ID: 6299236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of human herpesvirus 6 to antivirals in vitro.
    Burns WH; Sandford GR
    J Infect Dis; 1990 Sep; 162(3):634-7. PubMed ID: 2167336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic mechanisms of resistance to acyclovir in herpes simplex virus.
    Crumpacker CS; Schnipper LE; Chartrand P; Knopf KW
    Am J Med; 1982 Jul; 73(1A):361-8. PubMed ID: 6285723
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-Methoxymethyldeoxyuridine-resistant mutants of herpes simplex virus type 1.
    Veerisetty V; Gentry GA
    Virology; 1981 Oct; 114(2):576-9. PubMed ID: 6270889
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Coen DM; Fleming HE; Leslie LK; Retondo MJ
    J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
    Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
    Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of antiherpes drugs and drug resistant virus--effect of BVDU on varicella zoster virus replication].
    Shigeta S; Yokota T
    Rinsho Byori; 1985 Feb; 33(2):148-57. PubMed ID: 2987573
    [No Abstract]   [Full Text] [Related]  

  • 11. Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus.
    Swierkosz EM; Arens MQ; Rivetna KA
    J Clin Microbiol; 1985 Mar; 21(3):459-61. PubMed ID: 2984249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
    Field H; McMillan A; Darby G
    J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
    Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
    N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
    [No Abstract]   [Full Text] [Related]  

  • 14. Properties of antiviral agents. 1.
    Nicholson KG
    Lancet; 1984 Sep; 2(8401):503-6. PubMed ID: 6147558
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir.
    Larder BA; Darby G
    Antimicrob Agents Chemother; 1986 May; 29(5):894-8. PubMed ID: 3015009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    Balzarini J; de Clercq E; Ayusawa D; Seno T
    FEBS Lett; 1985 Jun; 185(1):95-100. PubMed ID: 2987041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of varicella-zoster virus infection--mechanism of action of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Shigeta S; Yokota T; De Clercq E
    Antiviral Res; 1985; Suppl 1():35-44. PubMed ID: 3002264
    [No Abstract]   [Full Text] [Related]  

  • 18. Physical and biological consequences of incorporation of antiviral agents into virus DNA.
    Prusoff WH; Mancini WR; Lin TS; Lee JJ; Siegel SA; Otto MJ
    Antiviral Res; 1984 Dec; 4(6):303-15. PubMed ID: 6099709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins.
    Cheng YC; Dutschman G; De Clercq E; Jones AS; Rahim SG; Verhelst G; Walker RT
    Mol Pharmacol; 1981 Jul; 20(1):230-3. PubMed ID: 6270535
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance of herpes simplex virus to acycloguanosine--genetic and physical analysis.
    Crumpacker CS; Chartrand P; Subak-Sharpe JH; Wilkie NM
    Virology; 1980 Aug; 105(1):171-84. PubMed ID: 6251603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.